A Long-Term Safety Study of OZURDEX in Clinical Practice
Phase of Trial: Phase IV
Latest Information Update: 22 Apr 2016
At a glance
- Drugs Dexamethasone (Primary)
- Indications Retinal oedema
- Focus Adverse reactions
- Acronyms EPISODIC
- Sponsors Allergan
- 18 Apr 2016 Status changed from active, no longer recruiting to completed.
- 13 Oct 2015 Planned End Date changed from 1 Feb 2016 to 1 Mar 2016 as per ClinicalTrials.gov record.
- 13 Oct 2015 Planned primary completion date changed from 1 Feb 2016 to 1 Mar 2016 as per ClinicalTrials.gov record.